You just read:

Sorrento and Lee's Pharmaceutical Enter into Exclusive China Licensing Agreement to Develop and Commercialize Anti-PD-L1 antibody

News provided by

Sorrento Therapeutics, Inc.

Oct 03, 2014, 02:41 ET